Moreover, a recent study has indicated that high expression levels of hCSCs biomarkers, including CD133 and CD44, are correlated with tumor angiogenesis and poor prognosis of HCC patients [15]. This evidence concerns the gene CD44 and hepatocellular carcinoma.